Insider files Form 144: 30,000-share option sale listed

Mark A. Goldsmith provided notice under Form 144 of proposed transactions in common stock.

Rhea-AI Filing Summary

Mark A. Goldsmith provided notice under Form 144 of proposed transactions in common stock. The filing shows a prior sale of 15,394 common shares on 12/16/2025 for $1,182,525.52. It also lists a proposed transaction involving 30,000 common shares on 03/02/2026 tied to an exercise of stock options through Morgan Stanley Smith Barney LLC with $3,060,600.00 shown in the excerpt.

Insights

Corporate Governance Analyst

Form 144 reports proposed insider sales and an option exercise.

The filing lists a prior sale of 15,394 common shares on 12/16/2025 for $1,182,525.52, which is an executed transaction disclosed in the notice. The excerpt also lists a proposed 30,000-share sale on 03/02/2026 tied to an exercise of stock options.

Cash-flow treatment for the proposed transaction is shown as Cash and the broker-dealer named is Morgan Stanley Smith Barney LLC. Timing and final sale mechanics depend on transaction execution; subsequent filings may report completion.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Mark A. Goldsmith report in the Form 144 for RVMD?

He reported a prior sale of 15,394 shares and a proposed 30,000-share transaction. The filing shows a sale on 12/16/2025 for $1,182,525.52 and a proposed option-related transaction for $3,060,600.00 on 03/02/2026.

How many shares were sold by Mark A. Goldsmith on 12/16/2025?

15,394 common shares were sold on 12/16/2025. The excerpt lists the sale proceeds as $1,182,525.52, reflecting the reported transaction in the Form 144 notice.

What is the proposed 03/02/2026 transaction listed in the filing?

The filing lists a proposed transaction of 30,000 common shares on 03/02/2026 tied to an exercise of stock options. The broker-dealer named is Morgan Stanley Smith Barney LLC and $3,060,600.00 appears in the excerpt.

Who is the broker-dealer handling the proposed sale?

Morgan Stanley Smith Barney LLC is named in the excerpt as the broker-dealer. The filing line identifies Morgan Stanley Smith Barney LLC with the 30,000-share entry dated 03/02/2026.

Does the Form 144 confirm the 30,000-share sale was completed?

The excerpt lists the 30,000-share transaction as an exercise of stock options on 03/02/2026. The notice records the proposed transaction; completion and final sale reporting would appear in subsequent filings if executed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:32 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001246842
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	REVOLUTION MEDICINES INC.
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	6504816801
Name of Person for Whose Account the Securities are To Be Sold	MARK A GOLDSMITH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30000	3060600.00	198173397	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Exercise of Stock Options	Issuer			30000	03/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK A GOLDSMITH 700 Saginaw Drive Redwood City CA 94063	Common	12/16/2025	15394	1182525.52

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark A Goldsmith
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)